Climate change is increasingly shaping how healthcare systems operate, with radiology positioned among the services expected to contribute to sustainability efforts. Progress can be difficult to translate into day-to-day practice when departments face budget constraints, competing clinical priorities and operational pressures that can push environmental initiatives behind immediate patient care demands. Within that context, iodine-based contrast media is presented as a pragmatic focal point. Rather than treating contrast conservation as a policy burden, iodine reduction is framed as a locally actionable economic opportunity for radiology leaders, with potential benefits that sit alongside clinical operations.
Sustainability Pressures and Implementation Constraints
Radiology departments operate within complex systems where sustainability goals must compete with clinical throughput, staffing, capital planning and short-term operational requirements. This environment can create a perceived tension between environmental stewardship and the immediate work of caring for patients. The result can be slow adoption of initiatives even when the rationale is widely accepted, particularly when changes require new investment, workflow redesign or multi-stakeholder alignment.
Must Read: Safe Contrast Use in Breast Imaging
A sustainability approach that prioritises reachable, bounded targets is positioned as a way to navigate these constraints. Iodine contrast media is presented as one such target because it supports a defined set of operational decisions and procurement choices. The framing centres on levers that can be led within departments and supported through business cases, rather than relying on broad system-wide policy mechanisms. This perspective highlights implementation barriers as a core challenge, with the need for approaches that can fit within existing pressures while still delivering measurable reductions in waste and resource use.
Iodine Contrast at the Intersection of Sustainability and Supply Risk
Iodinated contrast use is described as accounting for less than 0.4% of departmental greenhouse gas emissions. That proportion is used to make a different point: contrast media sits outside the trajectory expected for energy-related emissions, which are anticipated to decline as electricity grids decarbonise. Contrast media therefore requires active intervention rather than passive improvement through wider infrastructure change.
Iodine is also described as a non-renewable resource, with contrast media comprising 28% of global iodine consumption. This positions contrast use within both environmental considerations and supply chain vulnerability. The 2022 iodinated contrast shortage is cited as an illustration of that vulnerability and as a practical reminder that resource constraints can translate quickly into operational disruption. In this framing, sustainability is linked not only to emissions, but also to the resilience of imaging services that depend on stable access to contrast agents.
The discussion also points to opportunities to broaden the approach beyond iodinated contrast alone. Similar reduction strategies are suggested as potentially applicable to gadolinium-based agents used in magnetic resonance imaging (MRI). Additional considerations are raised for future development, including patient-related factors such as contrast reaction management costs and the potential for contrast reclamation or recycling programmes. Uncertainty is acknowledged through varying tariff conditions, with further considerations including how strategies might perform across different practice environments such as academic centres versus community hospitals and inpatient versus outpatient imaging. Regional variation in contrast pricing and availability is also identified as a factor that could influence feasibility and outcomes, with the underlying approach positioned as adaptable to local context and to other contrast-dependent modalities.
Practical Steps Now and the Role of Emerging Technologies
Two immediate actions are described as achievable using current clinically available technologies. One option involves smaller capital investment through multidose injector systems, which can minimise wasted contrast and reduce overall supply use. A second option is presented for departments not able to purchase capital equipment, focused on confirming that contrast vial sizes match the dose required in order to minimise waste and optimise use. Both actions are positioned as operationally grounded decisions that connect procurement and workflow to conservation outcomes.
Looking forward, iodine reduction techniques linked to photon-counting computed tomography (CT) and artificial intelligence (AI) algorithms are discussed in terms of their potential to support dose reduction while maintaining image quality. Protocols are described as still in development, and estimates of financial and environmental benefits are characterised as hypothetical, while still potentially useful in guiding future research directions and investment priorities.
At the same time, the environmental and economic impacts of AI algorithms and photon-counting CT are described as not well understood. This uncertainty is presented as a constraint on confident decision-making, supporting the need for robust life-cycle assessments that weigh the financial and environmental impacts of these technologies against any savings opportunities they might enable. The emphasis remains on balancing intended benefits with a fuller accounting of upstream and downstream effects, particularly when sustainability goals are used to justify technology adoption.
Iodine contrast conservation is presented as a practical sustainability lever that also addresses supply chain vulnerability, with a focus on feasible implementation rather than abstract commitment. The emphasis rests on operational choices available now, potential expansion to other contrast agents and modalities and a forward view that considers photon-counting CT and AI as emerging contributors to iodine reduction while recognising that their full impacts remain uncertain. Sustained progress is linked to combining multiple strategies to preserve iodine availability until a more circular economic pathway becomes available, with institutional inertia identified as a central barrier to turning identified solutions into routine practice.
Source: Journal of the American College of Radiology
Image Credit: iStock
